These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9013473)

  • 61. Enhanced antitumor effect of recombinant human tumor necrosis factor in combination with recombinant human granulocyte colony-stimulating factor in BALB/c mice.
    Maeda M; Watanabe N; Tsuji N; Tsuji Y; Okamoto T; Sasaki H; Akiyama S; Niitsu Y
    Jpn J Cancer Res; 1993 Aug; 84(8):921-7. PubMed ID: 7691787
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors.
    Mokyr MB; Hengst JC; Dray S
    Cancer Res; 1982 Mar; 42(3):974-9. PubMed ID: 6977410
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Deficient antigen presentation by Langerhans cells from athymic (nu/nu) mice. Restoration with thymic transplantation or administration of cytokines.
    Grabbe S; Gallo RL; Lindgren A; Granstein RD
    J Immunol; 1993 Oct; 151(7):3430-9. PubMed ID: 8376784
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha.
    Musiani P; Allione A; Modica A; Lollini PL; Giovarelli M; Cavallo F; Belardelli F; Forni G; Modesti A
    Lab Invest; 1996 Jan; 74(1):146-57. PubMed ID: 8569177
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Combination therapy of murine tumors with a degraded D-manno-D-glucan (DMG) from Microellobosporia grisea, and cyclophosphamide.
    Nakajima H; Hashimoto S; Kita Y; Takashi T; Tsukada W; Kohno M; Ogawa H; Abe S; Mizuno D
    Jpn J Exp Med; 1983 Dec; 53(6):263-9. PubMed ID: 6240552
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth.
    Kawakita M; Rao GS; Ritchey JK; Ornstein DK; Hudson MA; Tartaglia J; Paoletti E; Humphrey PA; Harmon TJ; Ratliff TL
    J Natl Cancer Inst; 1997 Mar; 89(6):428-36. PubMed ID: 9091644
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation.
    Ohkawara Y; Lei XF; Stämpfli MR; Marshall JS; Xing Z; Jordana M
    Am J Respir Cell Mol Biol; 1997 May; 16(5):510-20. PubMed ID: 9160833
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Regression and prevention of autochthonous tumors induced by 3-methylcholanthrene after injection of a T-cell receptor alpha /beta positive and CD4/CD8 double negative T-cells.
    Wakasugi H; Miyazaki K; Maruoka H; Kato K; Miyata M; Sugimura T; Terada M
    Immunol Lett; 1999 Sep; 69(3):329-37. PubMed ID: 10528797
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy.
    Narvaiza I; Mazzolini G; Barajas M; Duarte M; Zaratiegui M; Qian C; Melero I; Prieto J
    J Immunol; 2000 Mar; 164(6):3112-22. PubMed ID: 10706701
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A new method of antitumor therapy with a high dose of TNF perfusion for unresectable liver tumors.
    Nakamoto T; Inagawa H; Takagi K; Soma G
    Anticancer Res; 2000; 20(6A):4087-96. PubMed ID: 11131677
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Protective specific immunity induced by cyclophosphamide plus tumor necrosis factor alpha combination treatment of EL4-lymphoma-bearing C57BL/6 mice.
    Krawczyk CM; Verstovsek S; Ujházy P; Maccubbin D; Ehrke MJ
    Cancer Immunol Immunother; 1995 Jun; 40(6):347-57. PubMed ID: 7627991
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K; Tanaka T; Takeuchi M
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Enhancement of anti-cancer immunity by a lipoteichoic-acid-related molecule isolated from a penicillin-killed group A Streptococcus.
    Okamoto M; Ohe G; Oshikawa T; Furuichi S; Nishikawa H; Tano T; Ahmed SU; Yoshida H; Moriya Y; Saito M; Sato M
    Cancer Immunol Immunother; 2001 Oct; 50(8):408-16. PubMed ID: 11726135
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antitumor effect of recombinant tumor necrosis factor-alpha against murine sarcomas at visceral sites: tumor size influences the response to therapy.
    Mulé JJ; Asher A; McIntosh J; Lafreniere R; Shiloni E; Lefor A; Reichert CM; Rosenberg SA
    Cancer Immunol Immunother; 1988; 26(3):202-8. PubMed ID: 3383204
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
    Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
    Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267
    [TBL] [Abstract][Full Text] [Related]  

  • 76. T cell involvement in production of tumor necrosis factor: reconstitution experiments with nude mice.
    Niitsu Y; Watanabe N; Sone H; Neda H; Urushizaki I
    Jpn J Cancer Res; 1985 May; 76(5):395-9. PubMed ID: 3924713
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antitumor efficacy induced by human ovarian cancer cells secreting IL-21 alone or combination with GM-CSF cytokines in nude mice model.
    Dou J; Wang Y; Wang J; Zhao F; Li Y; Cao M; Hu W; Hu K; He XF; Chu L; Jiang C; Gu N
    Immunobiology; 2009; 214(6):483-92. PubMed ID: 19389515
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
    Xie Y; Bai O; Zhang H; Li W; Xiang J
    Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Antitumor activity of Ge-132, a new organogermanium compound, in mice is expressed through the functions of macrophages and T lymphocytes].
    Suzuki F
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1445-52. PubMed ID: 3874600
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Preventive Effect of Oral Administration of
    Zhang R; Inagawa H; Uchibori S; Masaki T; Kobara H; Soma GI
    Anticancer Res; 2019 Aug; 39(8):4503-4509. PubMed ID: 31366552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.